These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 4047515)

  • 1. Central nervous system effect of 2,5-hexane diol.
    Agrawal AK; Goel SK; Seth PK; Pandya KP
    Neurotoxicology; 1985; 6(3):53-9. PubMed ID: 4047515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of gestational and neonatal styrene exposure on dopamine receptors.
    Zaidi NF; Agrawal AK; Srivastava SP; Seth PK
    Neurobehav Toxicol Teratol; 1985; 7(1):23-8. PubMed ID: 4039799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural and neurochemical changes in offspring of rats exposed to methyl mercury during gestation.
    Cuomo V; Ambrosi L; Annau Z; Cagiano R; Brunello N; Racagni G
    Neurobehav Toxicol Teratol; 1984; 6(3):249-54. PubMed ID: 6541762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of in vitro serotonin on dopaminergic binding sites in rat striatal membranes].
    Oelssner W; Raubach KH; Oelssner W
    Biomed Biochim Acta; 1983; 42(7-8):931-6. PubMed ID: 6651809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging and the regulation of striatal dopaminergic mechanisms in mice.
    Randall PK; Severson JA; Finch CE
    J Pharmacol Exp Ther; 1981 Dec; 219(3):695-700. PubMed ID: 7197719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic haloperidol, thioridazine and zotepine treatment on apomorphine elicited stereotypic behavior and 3H-spiroperidol binding sites in the striatum of the rat.
    Lai HC; Carino MA; Horita A
    Proc West Pharmacol Soc; 1981; 24():5-6. PubMed ID: 6114496
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
    J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.
    Akiyama K; Sato M; Otsuki S
    Biol Psychiatry; 1982 Feb; 17(2):223-31. PubMed ID: 7200378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-oxides of phenothiazine antipsychotics: effects on in vivo and in vitro estimates of dopaminergic function.
    Lewis MH; Widerlöv E; Knight DL; Kilts CD; Mailman RB
    J Pharmacol Exp Ther; 1983 Jun; 225(3):539-45. PubMed ID: 6134814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodone interaction with apomorphine- and amphetamine-induced turning.
    Stratten WP
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):675-8. PubMed ID: 1237160
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of functionally-relevant serum levels of MJ 13859-1 in the dog: relationship to blockade of amphetamine stereotypy.
    Eison MS; Taylor DP; Riblet LA; Temple DL
    Methods Find Exp Clin Pharmacol; 1984 May; 6(5):255-9. PubMed ID: 6540833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
    Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between agents stimulating and inhibiting the central dopamine receptors and octopamine.
    Jagiełło-Wójtowicz
    Acta Physiol Pol; 1980; 31(2):153-8. PubMed ID: 6771963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of potentiation of apomorphine-induced stereotypy due to electroconvulsive shock.
    Gulati A; Srimal RC; Dhawan KN; Dhawan BN
    Neuropharmacology; 1987 Dec; 26(12):1733-7. PubMed ID: 3437939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dietary haloperidol regimen for inducing dopamine receptor supersensitivity in rats.
    Frey JM; Morgan WW; Ticku MK; Huffman RD
    Pharmacol Biochem Behav; 1987 Apr; 26(4):661-9. PubMed ID: 3602028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine induces hypermotility in MPTP-lesioned mice.
    Schroeder U; Kreutz MR; Schroeder H; Sabel BA
    Pharmacol Biochem Behav; 1997 Feb; 56(2):281-5. PubMed ID: 9050086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptors in the striatum and limbic system of various strains of mice: relation to differences in responses to apomorphine.
    Michaluk J; Antkiewicz-Michaluk L; Rokosz-Pelc A; Sansone M; Oliverio A; Vetulani J
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1115-8. PubMed ID: 6891791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.